Summit Therapeutics Inc.
NASDAQSummit Therapeutics heads into its May 4 Q1 print riding a sharp reversal — up 26% in a month — while options traders quietly lean more bullish than at almost any point this year. The clearest positioning signal is in the options market, where the put/call ratio has drifted to 0.62 — below its 20-day average of 0.65 and approaching its 52-week low of 0.50. That tilt reflects…
Snapshot as of 8 May 2026
Summit Therapeutics heads into its May 4 Q1 print riding a sharp reversal — up 26% in a month — while options traders quietly lean more bullish than at almost any point this year. The clearest positioning signal is in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SMMT — free to start on ORTEX.
Sign up for free →Open SMMT on ORTEX